Valérie Reader

1.9k total citations
8 papers, 128 citations indexed

About

Valérie Reader is a scholar working on Molecular Biology, Biological Psychiatry and Organic Chemistry. According to data from OpenAlex, Valérie Reader has authored 8 papers receiving a total of 128 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Biological Psychiatry and 2 papers in Organic Chemistry. Recurrent topics in Valérie Reader's work include Inflammasome and immune disorders (4 papers), Tryptophan and brain disorders (3 papers) and Adenosine and Purinergic Signaling (1 paper). Valérie Reader is often cited by papers focused on Inflammasome and immune disorders (4 papers), Tryptophan and brain disorders (3 papers) and Adenosine and Purinergic Signaling (1 paper). Valérie Reader collaborates with scholars based in United Kingdom, United States and Germany. Valérie Reader's co-authors include David Harrison, Alan P. Watt, Colin M. Tice, John Reader, Enrique L. Michelotti, Matthew Stirling, Pamela J. Smolak, Zsofia Digby, Peter Thornton and Andy Billinton and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Movement Disorders.

In The Last Decade

Valérie Reader

7 papers receiving 121 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Valérie Reader United Kingdom	4	69	36	19	12	10	8	128
Yanna Tian United States	7	84 1.2×	26 0.7×	23 1.2×	10 0.8×	4 0.4×	14	174
Christopher A. Luckhurst United Kingdom	8	139 2.0×	58 1.6×	12 0.6×	27 2.3×	3 0.3×	11	203
Justyna M. Gawel Canada	5	181 2.6×	25 0.7×	12 0.6×	14 1.2×		6	229
Tine Glendorf Denmark	9	143 2.1×	9 0.3×	5 0.3×	8 0.7×	5 0.5×	17	325
Jessica D. Rosarda United States	7	102 1.5×	4 0.1×	13 0.7×	35 2.9×	9 0.9×	12	163
Dongming Qian China	3	95 1.4×	9 0.3×	15 0.8×	19 1.6×		5	145
Xiaorui Zhou China	5	45 0.7×	5 0.1×	8 0.4×	17 1.4×	7 0.7×	10	84
Nicolas Szabo‐Fresnais United States	6	132 1.9×	9 0.3×	23 1.2×	9 0.8×		8	198
Mei Ding Singapore	6	77 1.1×	27 0.8×	3 0.2×	9 0.8×		13	147
Hideki Kozono Japan	3	44 0.6×	23 0.6×	4 0.2×	4 0.3×	3 0.3×	5	123

Countries citing papers authored by Valérie Reader

Since Specialization

Citations

This map shows the geographic impact of Valérie Reader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valérie Reader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valérie Reader more than expected).

Fields of papers citing papers by Valérie Reader

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valérie Reader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valérie Reader. The network helps show where Valérie Reader may publish in the future.

Co-authorship network of co-authors of Valérie Reader

This figure shows the co-authorship network connecting the top 25 collaborators of Valérie Reader. A scholar is included among the top collaborators of Valérie Reader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valérie Reader. Valérie Reader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Harrison, David, Andy Billinton, Mark G. Bock, et al.. (2025). Profile of NT-0527, a brain penetrant NLRP3 Inflammasome inhibitor suitable as an in vivo tool compound for neuroinflammatory disorders. RSC Medicinal Chemistry. 16(11). 5318–5332.

Thornton, Peter, Valérie Reader, Zsofia Digby, et al.. (2025). Anti‐Neuroinflammatory and Anti‐Inflammatory Effects of the NLRP3 Inhibitor NT ‐0796 in Subjects with Parkinson's Disease. Movement Disorders. 40(10). 2199–2208. 2 indexed citations

Thornton, Peter, et al.. (2025). The NLRP3 inhibitor NT‐0796 enhances and sustains GLP‐1R agonist‐mediated weight loss in a murine diet‐induced obesity model. Obesity. 33(7). 1309–1321. 2 indexed citations

Thornton, Peter, Valérie Reader, Zsofia Digby, et al.. (2024). Reversal of High Fat Diet-Induced Obesity, Systemic Inflammation, and Astrogliosis by the NLRP3 Inflammasome Inhibitors NT-0249 and NT-0796. Journal of Pharmacology and Experimental Therapeutics. 388(3). 813–826. 28 indexed citations

Harrison, David, Andy Billinton, Mark G. Bock, et al.. (2023). Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders. Journal of Medicinal Chemistry. 66(21). 14897–14911. 35 indexed citations

Joberty, Gérard, Markus Böesche, Jack A. Brown, et al.. (2016). Interrogating the Druggability of the 2-Oxoglutarate-Dependent Dioxygenase Target Class by Chemical Proteomics. ACS Chemical Biology. 11(7). 2002–2010. 23 indexed citations

Michelotti, Enrique L., et al.. (2001). Design, Synthesis, and Biological Evaluation of a Library of 1-(2-Thiazolyl)-5-(trifluoromethyl)pyrazole-4-carboxamides. Journal of Combinatorial Chemistry. 4(1). 23–32. 37 indexed citations

Reader, Valérie. (1998). An Efficient Synthesis of 2-(Methylaminomethyl)-4,5-Dialkyl-1H-Imidazoles. Synlett. 1998(10). 1077–1078. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact